This evaluation corrects sensitivity and specificity of DART in detecting diabetic retinopathy, suggesting reliable metrics are critical for AI-based tools.
To evaluate and correct the reported sensitivity and specificity values of DART (Diagnóstico Automatizado de Retinografías Telemáticas), an automated Artificial Intelligence based (AI-based) screening tool used for diabetic retinopathy (DR) detection in the Chilean public healthcare system, by employing the appropriate gold standard and conditional probability. Data were obtained from the clinical validation of DART. DR detection capabilities were assessed for three methods 1) Fundoscopy, 2) Retinography and 3) AI- DART. To estimate the true sensitivity and specificity of DART, conditional probability was applied using three hypothetical sensitivities level for method 2: A) Optimistic (90%), B) Moderate (80%), and C) Pessimistic (70%). Based on these scenarios, corrected sensitivity and specificity values for DART were calculated, along with false negative/positive rates (%FN/%FP), and predictive values (NPV/PPV). In all scenarios, corrected sensitivity and specificity values for DART were significantly lower than those reported in the original validation study. Compared to method 3 (AI-based), method 2 (retinography by and ophthalmologist) consistently demonstrated superior performance across all metrics, including FN%, FP%, NPV and PPV values. While the integration of new AI-based technologies like DART in healthcare offer promise for enhancing patient care, their implementation must be preceded by validation using the correct gold standard. Reliable clinical decision-making depends on trustworthy diagnostic parameters.
No takes yet. Share an insight, caveat, or question.
Segovia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: